PROJECT SKQ
mitochondrial antioxidants of targeted action
based on Skulachev ions

New possibilities opened up only in the beginning of this century. In 2004, a new substance was synthesized by the group of professor Vladimir P. Skulachev in the Moscow State University. Our project team later gave the substance its “production” name “SkQ1".

Two commercial entities Mitotech Russia and Mitotech EU were established around 2010 with an aim to develop SkQ1 into a preparation targeting several age-related indications. Targeted therapeutic areas include ophthalmic and neurodegenerative disorders. The companies are running their clinical programs in different geographical markets with a common goal of making SkQ1-based preparations available to patients world-wide.